Market share of anti-osteoporosis drugs in public medical institutions China 2016
This statistic shows the market share of Chinese medicine anti-osteoporosis drugs in Chinese public medical institutions in 2015. In 2015, the Chinese anti-osteoporosis medicine Xian Ling Gu Bao had a market share of nearly 37 percent among public medical institutions in China.